nach oben

Modern Rheumatology

Erschienen in:

01.11.2013 | Original Article

Expression of CD44 in articular cartilage is associated with disease severity in knee osteoarthritis

verfasst von: Fang-Jie Zhang, Wei Luo, Shu-Guang Gao, Da-Zhi Su, Yu-Sheng Li, Chao Zeng, Guang-Hua Lei

Erschienen in: Modern Rheumatology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To investigate CD44 levels in articular cartilage of knee osteoarthritis (OA) and the relationship between CD44 and severity of the disease.

Methods

All 50 cartilage tissues included normal and OA cartilage, and were ascribed to the following four groups on the basis of modified Mankin score: normal, mild lesions, moderate lesions and severe lesions. CD44 levels in articular cartilage were assessed by immunohistochemical methods.

Results

CD44 levels were detected in all four groups. The difference in average gray value of CD44 expression showed statistical significance when compared between each group (P < 0.05). In addition, CD44 expression in each group correlated with disease severity, according to the modified Mankin score (ρ = −0.848, P < 0.01).

Conclusions

CD44 in articular cartilage is associated with progressive knee OA joint damage.

Knudson W, Aguiar DJ, Hua Q, Knudson CB. CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp Cell Res. 1996;228(2):216–28.PubMedCrossRef

Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA. 1992;89(24):12160–4.PubMedCrossRef

Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol. 2008;18(4):260–7.PubMedCrossRef

Bajorath J. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins. 2000;39(2):103–11.PubMedCrossRef

Hale LP, Haynes BF, McCachren SS. Expression of CD44 variants in human inflammatory synovitis. J Clin Immunol. 1995;15(6):300–11.PubMedCrossRef

Cooper DL, Dougherty GJ. To metastasize or not? Selection of CD44 splice sites. Nat Med. 1995;1(7):635–7.PubMedCrossRef

Tölg C, Hofmann M, Herrlich P, Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 1993;21(5):1225–9.PubMedCrossRef

Underhill C. CD44: the hyaluronan receptor. J Cell Sci. 1992;103 Pt 2:293–8.

Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor–ligand interaction between CD44 and osteopontin (Eta-1). Science. 1996;271(5248):509–12.PubMedCrossRef

10.

Ishii S, Ford R, Thomas P, Nachman A, Steele G Jr. Jessup JM.CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen. Surg Oncol. 1993;2(4):255–64.PubMedCrossRef

11.

Jalkanen S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol. 1992;116(3):817–25.PubMedCrossRef

12.

Salter DM, Godolphin JL, Gourlay MS, Lawson MF, Hughes DE, Dunne E. Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease. J Pathol. 1996;179(4):396–402.PubMedCrossRef

13.

Tibesku CO, Szuwart T, Ocken SA, Skwara A, Fuchs S. Increase in the expression of the transmembrane surface receptor CD44v6 on chondrocytes in animals with osteoarthritis. Arthritis Rheum. 2005;52(3):810–7.PubMedCrossRef

14.

Chow G, Nietfeld JJ, Knudson CB, Knudson W. Antisense inhibition of chondrocyte CD44 expression leading to cartilage chondrolysis. Arthritis Rheum. 1998;41(8):1411–9.PubMedCrossRef

15.

van der Sluijs JA, Geesink RG, van der Linden AJ, Bulstra SK, Kuyer R, Drukker J. The reliability of the Mankin score for osteoarthritis. J Orthop Res. 1992;10(1):58–61.PubMedCrossRef

16.

Dunn S, Kolomytkin OV, Waddell DD, Marino AA. Hyaluronan-binding receptors: possible involvement in osteoarthritis. Mod Rheumatol. 2009;19(2):151–5.PubMedCrossRef

17.

Fuchs S, Dankbar B, Wildenau G, Goetz W, Lohmann CH, Tibesku CO. Expression of the CD44 variant isoform 5 in the human osteoarthritic knee joint: correlation with radiological, histomorphological, and biochemical parameters. J Orthop Res. 2004;22(4):774–80.PubMedCrossRef

18.

Chow G, Knudson CB, Homandberg G, Knudson W. Increased expression of CD44 in bovine articular chondrocytes by catabolic cellular mediators. J Biol Chem. 1995;270(46):27734–41.PubMedCrossRef

19.

Nishida Y, D’Souza AL, Thonar EJ, Knudson W. Stimulation of hyaluronan metabolism by interleukin-1alpha in human articular cartilage. Arthritis Rheum. 2000;43(6):1315–26.PubMedCrossRef

20.

Knudson W, Loeser RF. CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell Mol Life Sci. 2002;59(1):36–44.PubMedCrossRef

21.

Knudson CB, Nofal GA, Pamintuan L, Aguiar DJ. The chondrocyte pericellular matrix: a model for hyaluronan-mediated cell–matrix interactions. Biochem Soc Trans. 1999;27(2):142–7.PubMed

22.

Hua Q, Knudson CB, Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci. 1993;106(Pt 1):365–75.PubMed

23.

Embry JJ, Knudson W. G1 domain of aggrecan cointernalizes with hyaluronan via a CD44-mediated mechanism in bovine articular chondrocytes. Arthritis Rheum. 2003;48(12):3431–41.PubMedCrossRef

24.

Isacke CM. The role of the cytoplasmic domain in regulating CD44 function. J Cell Sci. 1994;107(Pt 9):2353–9.PubMed

25.

Lokeshwar VB, Fregien N, Bourguignon LY. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol. 1994;126(4):1099–109.PubMedCrossRef

26.

Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol. 1994;126(2):391–401.PubMedCrossRef

27.

Yasuda T. Activation of Akt leading to NF-κB up-regulation in chondrocytes stimulated with fibronectin fragment. Biomed Res. 2011;32(3):209–15.PubMedCrossRef

28.

Yasuda T, Poole AR, Shimizu M, Nakagawa T, Julovi SM, Tamamura H, et al. Involvement of CD44 in induction of matrix metalloproteinases by a COOH-terminal heparin-binding fragment of fibronectin in human articular cartilage in culture. Arthritis Rheum. 2003;48(5):1271–80.PubMedCrossRef

29.

Larkin J, Renukaradhya GJ, Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR. CD44 differentially activates mouse NK T cells and conventional T cells. J Immunol. 2006;177(1):268–79.PubMed

30.

Clark RA, Alon R, Springer TA. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol. 1996;134(4):1075–87.PubMedCrossRef

31.

de la Motte CA, Hascall VC, Drazba J, Bandyopadhyay SK, Strong SA. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid: polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol. 2003;163(1):121–33.PubMedCrossRef

32.

Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, et al. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J. 2002;21(15):3949–59.PubMedCrossRef

33.

Mikecz K, Dennis K, Shi M, Kim JH. Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum. 1999;42(4):659–68.PubMedCrossRef

34.

Neidhart M, Gay RE, Gay S. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2000;43(8):1719–28.PubMedCrossRef

35.

Sato MI, Koshino T. Takagi T.CD44 expression on chondrocytes in knees of DBA/1 mice with type II collagen-induced arthritis. Clin Exp Rheumatol. 1999;17(2):185–90.PubMed

Titel: Expression of CD44 in articular cartilage is associated with disease severity in knee osteoarthritis
verfasst von: Fang-Jie Zhang
Wei Luo
Shu-Guang Gao
Da-Zhi Su
Yu-Sheng Li
Chao Zeng
Guang-Hua Lei
Publikationsdatum: 01.11.2013
Verlag: Springer Japan
Erschienen in: Modern Rheumatology / Ausgabe 6/2013
Print ISSN: 1439-7595
Elektronische ISSN: 1439-7609
DOI: https://doi.org/10.1007/s10165-012-0818-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Expression of CD44 in articular cartilage is associated with disease severity in knee osteoarthritis

Abstract

Objectives

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2013

Interferon regulatory factor 5 polymorphisms in sarcoidosis

Recurrence of IgG4-related disease following treatment with rituximab

Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients

Giant cell arteritis of the thyroid in a 69-year-old male

Shorter disease duration is important for tocilizumab to achieve Boolean remission

Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin